Total Payments
$7,187
2024 Payments
$1,168
Companies
21
Transactions
106
Medicare Patients
88
Medicare Billing
$26,140
Payment Breakdown by Category
Food & Beverage$7,105 (98.9%)
Other$46.66 (0.6%)
Education$35.45 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,105 | 100 | 98.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46.66 | 2 | 0.6% |
| Education | $35.45 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,470 | 23 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,416 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $761.33 | 11 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $650.88 | 7 | $0 (2022) |
| United Therapeutics Corporation | $606.53 | 7 | $0 (2024) |
| Mylan Specialty L.P. | $282.77 | 3 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $267.62 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $233.77 | 3 | $0 (2024) |
| PFIZER PHARMACEUTICALS LLC | $229.31 | 3 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $219.76 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,168 | 14 | AstraZeneca Pharmaceuticals LP ($245.00) |
| 2023 | $333.22 | 6 | GlaxoSmithKline, LLC. ($133.52) |
| 2022 | $497.69 | 6 | GlaxoSmithKline, LLC. ($124.78) |
| 2021 | $821.61 | 11 | GlaxoSmithKline, LLC. ($248.97) |
| 2020 | $168.41 | 4 | GlaxoSmithKline, LLC. ($166.41) |
| 2019 | $1,697 | 25 | Boehringer Ingelheim Pharmaceuticals, Inc. ($351.50) |
| 2018 | $1,219 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($463.97) |
| 2017 | $1,283 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($401.17) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $104.68 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $82.31 | General |
| Category: NEUROLOGY | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $92.58 | General |
| Category: Cardiovascular | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $51.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $51.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $55.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $44.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 03/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: VACCINE | ||||||
| 02/08/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/23/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: IMMUNOLOGY | ||||||
| 06/10/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $57.04 | General |
| Category: Respiratory | ||||||
| 03/30/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $122.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $99.43 | General |
| Category: IMMUNOLOGY | ||||||
| 03/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $43.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | COMBIVENT RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $88.20 | General |
| Category: RESPIRATORY | ||||||
| 07/07/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $95.85 | General |
| Category: PAH | ||||||
| 05/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $114.74 | General |
| Category: Hematology | ||||||
| 05/12/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $124.78 | General |
| Category: IMMUNOLOGY | ||||||
| 03/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 25 | 84 | $10,121 | $7,613 |
| 2020 | 3 | 63 | 219 | $23,665 | $18,527 |
Total Patients
88
Total Services
303
Medicare Billing
$26,140
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 70 | $7,295 | $5,630 | 77.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 14 | $2,826 | $1,983 | 70.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 25 | 125 | $13,284 | $10,552 | 79.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 23 | 26 | $5,366 | $3,989 | 74.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 68 | $5,015 | $3,986 | 79.5% |
About Andres Bermudez Caba
Andres Bermudez Caba is a Pulmonary Disease healthcare provider based in Coto Laurel, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164525705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andres Bermudez Caba has received a total of $7,187 in payments from pharmaceutical and medical device companies, with $1,168 received in 2024. These payments were reported across 106 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($7,105).
As a Medicare-enrolled provider, Bermudez Caba has provided services to 88 Medicare beneficiaries, totaling 303 services with total Medicare billing of $26,140. Data is available for 2 years (2020–2021), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Coto Laurel, PR
- Active Since 09/07/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164525705
Products in Payments
- NUCALA (Biological) $868.73
- Adempas (Drug) $650.88
- ELIQUIS (Drug) $463.08
- TYVASO (Drug) $344.36
- OFEV (Drug) $335.06
- ACTHAR (Biological) $333.61
- TRELEGY ELLIPTA (Drug) $318.43
- BEVESPI AEROSPHERE (Drug) $288.21
- XARELTO (Drug) $267.62
- FASENRA (Biological) $177.04
- WINREVAIR (Biological) $176.08
- TEZSPIRE (Biological) $175.00
- ORENITRAM (Drug) $166.12
- TEFLARO (Drug) $142.67
- CHANTIX (Drug) $123.97
- MERLIN@HOME (Device) $104.68
- Dymista (Drug) $104.21
- Yupelri (Drug) $100.78
- OPSUMIT (Drug) $98.62
- LifeVest (Device) $98.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.